三叉神经微血管减压术治疗药物难治性SUNHA的单中心回顾性分析
该单中心回顾性分析纳入19例药物难治性短持续单侧神经痛样头痛发作(SUNHA)患者,评估三叉神经微血管减压术(MVD)的疗效与安全性。术后89.0%患者为应答者,最终随访时72.2%维持应答,平均随访54.3个月,仅少数出现短暂并发症。
要点
- 三叉神经MVD对药物难治性SUNHA可能安全有效。
- 术后89.0%应答,最终随访72.2%维持应答。
- 术前MRI显示三叉神经血管冲突伴形态改变者可能获益。
核心结论
- 三叉神经MVD可能对药物难治性且MRI显示三叉神经血管冲突伴形态改变的SUNHA患者安全有效。
研究设计与样本
- 单中心回顾性分析前瞻性收集数据,2012年9月至2025年3月连续纳入适合手术的难治性慢性SUNHA患者。
- 研究组19例SUNHA患者(女7例),平均年龄58岁(±12,范围35-81),药物难治(BNI评分=5),均行三叉神经MVD。
- 分析纳入18例患者,术前均行含特定三叉神经序列的MRI,采用5分BNI疼痛强度评分评估手术反应。
主要发现
- 18例分析患者中13例(72.2%)发现三叉神经血管冲突伴形态改变。
- 术后16例(89.0%)为应答者(BNI 1-2分),2例(11.1%)BNI 3分提示部分改善。
- 平均术后随访54.3个月(±36.7,范围2-163个月),最终随访时13例(72.2%)维持应答。
- 1例报告术后短暂头晕,1例报告切口部位疼痛。
关键数值与推荐
- 采用5分Barro神经学研究所(BNI)疼痛强度评分,最终随访BNI 1-2分定义为应答者。
临床怎么用
- 对药物难治性SUNHA患者,若MRI显示同侧三叉神经血管冲突伴形态改变,可考虑三叉神经MVD。
- 术前需行含特定三叉神经序列的MRI评估神经血管冲突。
- 术后需长期随访,因部分患者应答可能随时间减弱。
局限性
- 单中心回顾性分析,样本量小(分析18例)。
- 缺乏对照组,结论需更大样本前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This analysis aims to evaluate the sustained effectiveness of trigeminal microvascular decompression (MVD) in patients with medically refractory short-lasting unilateral neuralgiform headache attacks (SUNHA) who demonstrate trigeminal neurovascular conflict (NVC) ipsilateral to the painful side. METHODS: This is a retrospective single-center analysis of prospectively collected data conducted between September 2012 and March 2025 to investigate the efficacy and safety of trigeminal MVD in consecutive refractory chronic SUNHA patients suitable for surgery. All patients underwent a magnetic resonance imaging with specific trigeminal sequences before surgery. The 5-point Barrow Neurological Institute (BNI) pain intensity score was used to quantify the response to surgery. Patients with a BNI of 1-2 at the final postsurgery follow-up were considered responders. RESULTS: The study group consisted of 19 SUNHA patients (n = 7 female), with a mean age of 58 (±12, range 35-81), refractory to medical therapy (BNI score = 5), who underwent trigeminal MVD. Of the 18 patients included in the analysis, trigeminal NVC with morphological changes was found in 13 patients (72.2%). Postoperatively, 16 patients (89.0%) were responders. Two patients had a BNI score of 3, reflecting a partial improvement (11.1%). The mean postsurgery follow-up was 54.3 months (±36.7, range 2-163 months). At the final follow-up, 13 patients remained responders (72.2%). One patient reported transient postoperative dizziness, and 1 patient reported pain in the incision site. CONCLUSIONS: Trigeminal MVD may be a safe and effective treatment modality for those patients with medically refractory SUNHA with magnetic resonance imaging evidence of trigeminal NVC with morphological changes.
引用
- Barazi S, Pak HL, Maratos E, et al. Trigeminal Microvascular Decompression for Medically Refractory Short-Lasting Unilateral Neuralgiform Headache Attacks: A Single-Center Retrospective Analysis. World Neurosurg. 2025. PMID: 40912608. doi:10.1016/j.wneu.2025.124432
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。